However, it occurs in only approximately 18% of neuroblastoma patients, while nearly 80% present with single-copy MYCN—a subgroup that includes low- and intermediate-risk NB and remains comparatively less explored [3,4]. The gene discussed is MYCN; the disease is neuroblastoma.